These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 6817959)

  • 21. [Protective effect of lithium carbonate in neutropenia induced by antiblastic agents and evaluation of its long-term efficacy].
    Spina MP; Ventura M; Lavecchia G; Bombara R; Giraldi B; Mensi F; Massari A; Rossi F; Santi G; Visca U
    Minerva Med; 1981 Dec; 72(49):3323-8. PubMed ID: 6796912
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effect of nandrolone decanoate on bone marrow suppression induced by cytostatic agents.
    Huys J; Van Vaerenbergh PM
    Clin Oncol; 1976 Sep; 2(3):207-14. PubMed ID: 1009703
    [No Abstract]   [Full Text] [Related]  

  • 23. Toxic effects of early adjuvant chemotherapy for breast cancer.
    Ludwig Breast Cancer Study Group
    Lancet; 1983 Sep; 2(8349):542-4. PubMed ID: 6136695
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of lithium on thrombopoiesis in patients with low platelet cell counts following chemotherapy or radiotherapy.
    Hager ED; Dziambor H; Höhmann D; Winkler P; Strama H
    Biol Trace Elem Res; 2001 Nov; 83(2):139-48. PubMed ID: 11762531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The effect of lithium carbonate on leukopenia after chemotherapy.
    Steinherz PG; Rosen G; Ghavimi F; Wang Y; Miller DR
    J Pediatr; 1980 May; 96(5):923-7. PubMed ID: 6767826
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
    Dubsky P; Sevelda P; Jakesz R; Hausmaninger H; Samonigg H; Seifert M; Denison U; Mlineritsch B; Steger G; Kwasny W; Stöger H; Bartsch R; Stierer M; Taucher S; Fridrik M; Schippinger W; Greil R; Pötter R; Gnant M;
    Clin Cancer Res; 2008 Apr; 14(7):2082-7. PubMed ID: 18381948
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oral uracil and tegafur compared with classic cyclophosphamide, methotrexate, fluorouracil as postoperative chemotherapy in patients with node-negative, high-risk breast cancer: National Surgical Adjuvant Study for Breast Cancer 01 Trial.
    Watanabe T; Sano M; Takashima S; Kitaya T; Tokuda Y; Yoshimoto M; Kohno N; Nakagami K; Iwata H; Shimozuma K; Sonoo H; Tsuda H; Sakamoto G; Ohashi Y
    J Clin Oncol; 2009 Mar; 27(9):1368-74. PubMed ID: 19204202
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Chemotherapy associated with surgical treatment in primary bronchial cancers].
    Karrer K
    Bronches; 1974; 24(2):56-69. PubMed ID: 4422178
    [No Abstract]   [Full Text] [Related]  

  • 29. Pancreatitis during combination chemotherapy.
    Newman CE; Ellis DJ
    Clin Oncol; 1979 Mar; 5(1):83-4. PubMed ID: 421389
    [No Abstract]   [Full Text] [Related]  

  • 30. Evaluation of toxicities induced by chemotherapy in breast cancer patients.
    Mehreen L; Khanam A
    Biomed Pharmacother; 2005 Oct; 59(9):524-7. PubMed ID: 16154313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Non-hematologic adverse effects of cytostatic drugs].
    Singer Z; Kozaczka A; Wilk J; Janas J
    Pol Tyg Lek; 1984 Nov; 39(47):1535-41. PubMed ID: 6240028
    [No Abstract]   [Full Text] [Related]  

  • 32. The leucocyte nadir, a predictor of chemotherapy efficacy?
    Kvinnsland S
    Br J Cancer; 1999 Aug; 80(11):1681. PubMed ID: 10468282
    [No Abstract]   [Full Text] [Related]  

  • 33. Feasibility and tolerability of sequential doxorubicin/paclitaxel followed by cyclophosphamide, methotrexate, and fluorouracil and its effects on tumor response as preoperative therapy.
    Gianni L; Baselga J; Eiermann W; Guillem Porta V; Semiglazov V; Lluch A; Zambetti M; Sabadell D; Raab G; Llombart Cussac A; Bozhok A; Martinez-Agulló A; Greco M; Byakhov M; Lopez Lopez JJ; Mansutti M; Valagussa P; Bonadonna G;
    Clin Cancer Res; 2005 Dec; 11(24 Pt 1):8715-21. PubMed ID: 16361558
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Has current adjuvant cytostatic therapy in radically operated breast cancer patients failed?].
    Sauter C
    Schweiz Med Wochenschr; 1983 Mar; 113(12):414-7. PubMed ID: 6857192
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CCNU, melphalan, methotrexate, and prednisone (CAMP) versus cyclophosphamide, methotrexate, and 5-fluorouracil (CMF) in the treatment of advanced breast cancer in postmenopausal women.
    Salimtschik M; Snel S; Havsteen H; Dombernowsky P; Mouridsen HT
    Cancer Treat Rep; 1980; 64(4-5):635-7. PubMed ID: 7000346
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cause-specific mortality in long-term survivors of breast cancer: A 25-year follow-up study.
    Hooning MJ; Aleman BM; van Rosmalen AJ; Kuenen MA; Klijn JG; van Leeuwen FE
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1081-91. PubMed ID: 16446057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Toilet mastectomy: palliative treatment in women with advanced breast cancer].
    Novoa Vargas A
    Ginecol Obstet Mex; 2002 Aug; 70():392-7. PubMed ID: 12448043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Side effects of FEC100].
    Endo A; Watanabe T; Kodama H; Shiga C; Kikuchi S; Yokota T
    Gan To Kagaku Ryoho; 2008 Mar; 35(3):467-70. PubMed ID: 18347396
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural history of more than 20 years of node-positive primary breast carcinoma treated with cyclophosphamide, methotrexate, and fluorouracil-based adjuvant chemotherapy: a study by the Cancer and Leukemia Group B.
    Weiss RB; Woolf SH; Demakos E; Holland JF; Berry DA; Falkson G; Cirrincione CT; Robbins A; Bothun S; Henderson IC; Norton L;
    J Clin Oncol; 2003 May; 21(9):1825-35. PubMed ID: 12721260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant cyclophosphamide, methotrexate, and fluorouracil in premonopausal patients with node-positive breast cancer: indirect comparison of dose and schedule in DBCG trials 77, 82, and 89.
    Ejlertsen B; Mouridsen HT; Jensen MB
    Acta Oncol; 2008; 47(4):662-71. PubMed ID: 18465334
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.